Earnings History Data for ProKidney Corp. (PROK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ProKidney Corp.

ProKidney LP is a late clinical-stage cellular therapeutics company focused on CKD. The company's lead product candidate includes REACT(TM) is a first-of-its-kind, patented disease-modifying autologous cellular therapy. ProKidney LP, formerly known as Suvretta Holdings Corp. III, is based in WINSTON-SALEM, N,C.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-11-2023 PM PROK ProKidney Corp. 392.87 -0.18 -0.19 -0.13 ProKidney GAAP EPS of -$0.18
[11/14/2023 6:26 AM]
1.49 -0.11 
(-7.19%)
1.81 0.21 
(13.12%)
1.38 - 14.19 1,681,297 630,000 24,452
28-03-2023 AH After the close
(Mar 28)
PROK PROKIDNEY CP 0.00 -0.11 -0.24 0.00 ProKidney GAAP EPS of -$0.11
[3/28/2023 4:47 PM]
11.80 -0.22 
(-1.87%)
12.03 0.0 
(0.00%)
5.14 - 14.19 175,318 660,000 1,716
14-11-2022 PM PROK PROKIDNEY CP 0.00 -0.13 -0.05 0.00 ProKidney GAAP EPS of -$0.13
[11/14/2022 6:42 AM]
11.14 -0.24 
(-2.07%)
0.0 0.0 
(0.00%)
6.19 - 14.00 88,212 30,000 0